Same Indication

Imatinib vs Lutetium Oxodotreotide

Imatinib vs Lutetium Oxodotreotide: Overview

This comparison examines the pharmacological differences between Imatinib and Lutetium Oxodotreotide.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Pharmacokinetics

Half-life: Imatinib β€” 18 hours.

Chemical Properties

Molecular Formula: Imatinib β€” C29H31N7O.

Molecular Weight: Imatinib β€” 493.6030 g/mol.

Type: Imatinib β€” Small molecule; Lutetium Oxodotreotide β€” Protein.